XML 120 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
 6 Months Ended
Jun. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
Stock-Based Compensation
 
We currently have two stock-based compensation plans, the Employee Stock Purchase Plan (the “ESPP”) and the 2008 Equity Incentive Plan (the “2008 Plan”).
 
The 2008 Plan provides for grants of stock options, stock appreciation rights, restricted stock awards, restricted stock units and incentive awards. The maximum aggregate number of shares of common stock that may be issued under this plan and to which awards may relate is 2,000,000 shares, and 803,046 shares remained available for grant under this plan as of June 30, 2013.  Exercises and vestings under our stock-based compensation plans resulted in no income tax-related benefits or charges to additional paid-in capital during the three and six months ended June 30, 2013 and 2012.
 
Stock Options
 
Our 2008 Plan provides that we may grant options on or shares of our common stock (and other types of equity awards) to members of our Board of Directors, employees, consultants and advisors. The exercise price per share of the options may be less than, equal to, or greater than the market price on the date the option is granted. The option period may not exceed 10 years from the date of grant. The vesting requirements for options granted by us range from immediate to 5 years.  We had no expenses related to stock option-related compensation costs during the three and six months ended June 30, 2013 and 2012. When applicable, we recognize stock option-related compensation expense for any awards with graded vesting on a straight-line basis over the vesting period for the entire award. Information related to options outstanding is as follows:

 
For the Six Months Ended June 30, 2013
 
Number of
Shares
 
Weighted-
Average
Exercise Price
 
Weighted-
Average of Remaining
Contractual Life
 
Aggregate
Intrinsic
Value
Outstanding at December 31, 2012
500,000

 
$
40.99

 
 
 
 
Issued/Cancelled/Forfeited
(500,000
)
 
$
40.99

 
 
 
 
Outstanding at June 30, 2013
—

 
$
—

 

 
$
—

Exercisable at June 30, 2013
—

 
$
—

 

 
$
—

 
For the Six Months Ended June 30, 2012
 
Number of
Shares
 
Weighted-
Average
Exercise Price
 
Weighted-
Average of Remaining
Contractual Life
 
Aggregate
Intrinsic
Value
Outstanding at December 31, 2011
570,000

 
$
39.24

 
 
 
 

Issued/Cancelled/Forfeited
(70,000
)
 
$
26.76

 
 
 
 

Outstanding at June 30, 2012
500,000

 
$
40.99

 
0.9
 
$
—

Exercisable at June 30, 2012
500,000

 
$
40.99

 
0.9
 
$
—


As of June 30, 2013, we had no outstanding stock options and thus had no unamortized deferred compensation costs associated with non-vested stock options. There were no stock option exercises during the three and six months ended June 30, 2013 and 2012, and we granted no options in the three and six months ended June 30, 2013 and 2012.


Restricted Stock and Restricted Stock Unit Awards
 
During the six months ended June 30, 2013 and 2012, we granted 150,472 and 60,000 shares of aggregate restricted stock and restricted stock units, respectively, with aggregate grant date fair values of $0.5 million and $0.2 million, respectively. When we grant restricted shares, we defer the grant date value of the restricted shares and amortize that value (net of the value of anticipated forfeitures) as compensation expense with an offsetting entry to the additional paid-in capital component of our consolidated shareholders’ equity. Our issued restricted shares generally vest over a range of 24 to 60 months and are being amortized to salaries and benefits expense ratably over applicable vesting periods. As of June 30, 2013, our unamortized deferred compensation costs associated with non-vested restricted stock awards were $0.7 million with a weighted-average remaining amortization period of 1.6 years.